Nasopulmonary drug delivery – introduction and principles MCQs With Answer

Introduction: Nasopulmonary drug delivery integrates nasal and pulmonary routes to achieve local, systemic, or nose-to-brain therapy. For B. Pharm students, understanding anatomy, mucociliary clearance, particle size, deposition mechanisms (impaction, sedimentation, diffusion), absorption enhancers, mucoadhesive polymers, and formulation types (solutions, suspensions, powders, gels) is essential. Key principles include avoiding enzymatic degradation, optimizing residence time, targeting the olfactory region for direct brain delivery, and selecting appropriate devices (sprays, nebulizers, DPIs). Regulatory, safety, and stability considerations guide formulation design. Core keywords: nasopulmonary drug delivery, nasal drug delivery, pulmonary delivery, mucociliary clearance, olfactory pathway, particle size, mucoadhesion. Now let’s test your knowledge with 30 MCQs on this topic.

Q1. Which anatomical region of the nasal cavity is primarily targeted for nose-to-brain drug delivery?

  • Respiratory region
  • Vestibule
  • Olfactory region
  • Nasopharynx

Correct Answer: Olfactory region

Q2. What is the main clearance mechanism that limits nasal residence time of formulations?

  • Phagocytosis
  • Mucociliary clearance
  • Transcytosis
  • Hepatic metabolism

Correct Answer: Mucociliary clearance

Q3. For deposition in the lower airways, which aerodynamic particle size (MMAD) is most appropriate?

  • >10 µm
  • 5–10 µm
  • 1–5 µm
  • <0.1 µm

Correct Answer: 1–5 µm

Q4. Which formulation approach increases nasal residence time by adhesive interaction with mucus?

  • Surfactant micelles
  • Mucoadhesive polymers (e.g., chitosan)
  • High-volatility solvents
  • Non-ionic osmolytes

Correct Answer: Mucoadhesive polymers (e.g., chitosan)

Q5. Which deposition mechanism dominates for particles >5 µm in the nasal cavity?

  • Brownian diffusion
  • Sedimentation
  • Inertial impaction
  • Electrostatic attraction

Correct Answer: Inertial impaction

Q6. Which device type is most suitable for delivering a dry powder to the nasal mucosa?

  • Nasal spray pump
  • Metered dose inhaler (pMDI)
  • Dry powder insufflator
  • Nebulizer

Correct Answer: Dry powder insufflator

Q7. Which factor most strongly influences aerosol deposition pattern in the lungs?

  • Drug pKa
  • Breathing pattern and inspiratory flow
  • Tablet hardness
  • Packaging color

Correct Answer: Breathing pattern and inspiratory flow

Q8. Why are absorption enhancers used in nasal formulations?

  • To change drug color
  • To increase mucociliary clearance
  • To transiently increase epithelial permeability
  • To accelerate hepatic metabolism

Correct Answer: To transiently increase epithelial permeability

Q9. Which physicochemical property of a drug favors passive transcellular nasal absorption?

  • High molecular weight and high polarity
  • Low lipophilicity and ionized state
  • Moderate lipophilicity and low molecular weight
  • Strong positive charge and >1000 Da

Correct Answer: Moderate lipophilicity and low molecular weight

Q10. The primary advantage of nasal delivery over oral administration is:

  • Higher susceptibility to gastric enzymes
  • Avoidance of first-pass hepatic metabolism
  • Lower formulation cost always
  • Guaranteed complete bioavailability

Correct Answer: Avoidance of first-pass hepatic metabolism

Q11. In nose-to-brain delivery, which neural pathway besides the olfactory nerve is important?

  • Optic nerve
  • Vagus nerve
  • Trigeminal nerve
  • Facial nerve

Correct Answer: Trigeminal nerve

Q12. Which parameter describes the mass median aerodynamic diameter of an aerosol?

  • Geometric standard deviation
  • MMAD — diameter at which 50% mass is contained in smaller particles
  • Count median diameter based on number distribution
  • Optical diameter from light scattering

Correct Answer: MMAD — diameter at which 50% mass is contained in smaller particles

Q13. Which excipient is commonly used in nasal sprays as a preservative but may cause ciliary toxicity?

  • Sodium chloride
  • Benzalkonium chloride
  • Glycerin
  • Polysorbate 80

Correct Answer: Benzalkonium chloride

Q14. What is the role of in situ gelling systems in nasal delivery?

  • They reduce drug solubility drastically
  • They form gels upon administration to prolong residence time
  • They increase spray velocity only
  • They convert drug into volatile form

Correct Answer: They form gels upon administration to prolong residence time

Q15. Which analytical technique is commonly used to visualize nasal deposition patterns in vivo?

  • Mass spectrometry with no imaging
  • Gamma scintigraphy
  • Fourier transform infrared spectroscopy on tissue sections
  • Thermogravimetric analysis

Correct Answer: Gamma scintigraphy

Q16. Which chemical modification can protect peptide drugs from nasal enzymatic degradation?

  • Adding free amine groups
  • Prodrug formation or PEGylation
  • Decreasing molecular weight
  • Increasing formulation acidity to pH 1

Correct Answer: Prodrug formation or PEGylation

Q17. Which statement about mucociliary clearance rate and nasal drug absorption is true?

  • Faster clearance increases absorption time
  • Slower clearance decreases drug contact time
  • Faster clearance reduces residence time and may reduce absorption
  • Clearance has no effect on absorption

Correct Answer: Faster clearance reduces residence time and may reduce absorption

Q18. For systemic delivery via pulmonary route, which property of particles is undesirable?

  • High respirable fraction (1–5 µm)
  • Aggregation increasing effective diameter
  • Appropriate hygroscopicity to avoid growth
  • Controlled-release matrix

Correct Answer: Aggregation increasing effective diameter

Q19. Which polymer is commonly used for nasal mucoadhesion and also acts as a permeation enhancer?

  • Polyethylene glycol (PEG 4000)
  • Chitosan
  • Polyvinyl chloride
  • Cellulose acetate phthalate

Correct Answer: Chitosan

Q20. What does the term ‘first-pass effect’ refer to in pharmacokinetics relevant to nasal delivery?

  • Metabolism occurring in the lungs before absorption
  • Initial absorption into lymphatics only
  • Hepatic metabolism that reduces oral bioavailability, often avoided by nasal route
  • Immediate renal excretion after nasal absorption

Correct Answer: Hepatic metabolism that reduces oral bioavailability, often avoided by nasal route

Q21. Which formulation parameter is critical to minimize nasal irritation and ensure compatibility?

  • Viscosity only
  • pH and osmolarity close to nasal physiological values
  • Maximum possible surfactant concentration
  • High ethanol content

Correct Answer: pH and osmolarity close to nasal physiological values

Q22. Which respiratory region is most involved in gas exchange and targeted by systemic pulmonary delivery?

  • Trachea
  • Bronchi
  • Alveolar region
  • Nasal vestibule

Correct Answer: Alveolar region

Q23. Which in vitro test is commonly used to evaluate nasal spray droplet size distribution?

  • Dissolution testing in paddle apparatus
  • Laser diffraction or cascade impaction
  • Flame photometry
  • Karl Fischer titration

Correct Answer: Laser diffraction or cascade impaction

Q24. Which strategy can enhance transcellular transport of polar drugs across nasal epithelium?

  • Use of tight junction openers only
  • Encapsulation in lipophilic nanoparticles or prodrug design
  • Decreasing particle size to >10 µm
  • Avoiding excipients altogether

Correct Answer: Encapsulation in lipophilic nanoparticles or prodrug design

Q25. Which safety concern is specifically associated with chronic intranasal use of certain preservatives?

  • Systemic hypertension in all patients
  • Ciliary toxicity and impaired mucociliary function
  • Increased liver enzymes universally
  • Permanent tooth staining

Correct Answer: Ciliary toxicity and impaired mucociliary function

Q26. Which characteristic of a nasal powder formulation promotes deposition in the upper nasal cavity?

  • Very small respirable particles (<1 µm)
  • Higher particle density and coarser particle size
  • Use of highly volatile solvents
  • Formulation as a liquid aerosol

Correct Answer: Higher particle density and coarser particle size

Q27. Which clinical application exploits nasal administration for acute systemic effect?

  • Topical antifungals for toenail
  • Intranasal sumatriptan for acute migraine
  • Oral extended-release antihistamines
  • Transdermal nicotine patch

Correct Answer: Intranasal sumatriptan for acute migraine

Q28. Which regulatory aspect is particularly evaluated for nasopulmonary products?

  • Color of packaging only
  • Aerosol performance, sterility, preservative safety, and device compatibility
  • Tablet friability only
  • Oral disintegration time

Correct Answer: Aerosol performance, sterility, preservative safety, and device compatibility

Q29. What is the effect of increased formulation viscosity on nasal drug delivery?

  • Always decreases absorption regardless of other factors
  • Increases residence time but may reduce diffusion and spray dispersion
  • Has no impact on mucociliary clearance
  • Causes immediate systemic toxicity

Correct Answer: Increases residence time but may reduce diffusion and spray dispersion

Q30. Which measurement provides information about airway resistance relevant to pulmonary delivery?

  • Rhinomanometry and spirometry
  • Mass spectrometry of drug
  • pH meter reading of formulation
  • Optical density of the aerosol

Correct Answer: Rhinomanometry and spirometry

Leave a Comment